Wikidata

(Q64173518)

English

A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis

clinical trial

In more languages

Statements

title
A Phase II, Single-arm, Open-label Study to Characterise the Effect on Portal Pressure, the Effect on Renal Function and the Pharmacokinetic Profile of N-003 in Patients With Decompensated Cirrhosis (English)
0 references
medical condition
arterial hypertension
0 references
liver cirrhosis
0 references
ascites
0 references
country
Spain
0 references
start time
11 April 2019
0 references
end time
30 September 2020
0 references
number of participants
24
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64173518&oldid=2062087136"